×
About 3,253 results

ALLMedicine™ Anal Cancer Center

Research & Reviews  994 results

Risk of Anorectal Cancer Associated with Benign Anal Inflammatory Diseases: A Retrospec...
https://doi.org/10.3390/ijerph19127467
International Journal of Environmental Research and Publi... Chae W, Kang SY et. al.

Jun 25th, 2022 - The purpose of our study was to evaluate the relationship between benign anal inflammatory diseases and anorectal cancer and assess its risk factors. A retrospective matched cohort study was conducted that included data from 2002 to 2013. The Nati...

Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
https://clinicaltrials.gov/ct2/show/NCT03946358

Jun 23rd, 2022 - 70% all cases of cervical cancer, 95% of anal cancers and about 70% of oropharyngeal cancers are linked to Human Papillomavirus (HPV) infection. HPV oncogenic proteins are trans-activators of telomerase. Indeed, E6 oncoprotein transactivates the h...

Follow-Up to High-Resolution Anoscopy After Abnormal Anal Cytology in People Living wit...
https://doi.org/10.1089/apc.2022.0057
AIDS Patient Care and STDs; Wells J, Flowers L et. al.

Jun 22nd, 2022 - Current expert recommendations suggest anal cytology followed by high-resolution anoscopy (HRA) for biopsy and histological confirmation may be beneficial in cancer prevention, especially in people living with HIV (PLWH). Guided by the social ecol...

Shared Decision-Making Concerning Anal Cancer Screening in Persons with HIV.
https://doi.org/10.1093/cid/ciac491
Clinical Infectious Diseases : an Official Publication Of... Cachay ER, Gilbert T et. al.

Jun 21st, 2022 - Anal high-grade squamous intraepithelial lesion (aHSIL) is the immediate precursor of anal cancer. Anal cytology is a recommended screening test to identify aHSIL among people with HIV (PWH). Heterogeneity of risk for invasive anal cancer among PW...

see more →

Guidelines  8 results

ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT...
https://doi.org/10.1016/j.prro.2022.01.015
Practical Radiation Oncology; Damico N, Meyer J et. al.

Jun 19th, 2022 - Previous anal cancer guidelines delineate target volumes similarly for all patients with squamous cell carcinoma of the anal canal and/or perianal skin (SCCA), regardless of disease stage. The purpose of this guideline is to provide customized rad...

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.
https://doi.org/10.1016/j.annonc.2021.06.015
Annals of Oncology : Official Journal of the European Soc... Rao S, Guren MG et. al.

Jun 28th, 2021 - Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.|2021|Rao S,Guren MG,Khan K,Brown G,Renehan AG,|diagnosis,epidemiology,therapy,

Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in ...
https://doi.org/10.6004/jnccn.2018.0066
Journal of the National Comprehensive Cancer Network : JN... Reid E, Suneja G et. al.

Aug 14th, 2018 - People living with HIV (PLWH) are diagnosed with cancer at an increased rate over the general population and generally have a higher mortality due to delayed diagnoses, advanced cancer stage, comorbidities, immunosuppression, and cancer treatment ...

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2018.0060
Journal of the National Comprehensive Cancer Network : JN... Benson AB, Venook AP et. al.

Jul 15th, 2018 - The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain les...

2016 IANS International Guidelines for Practice Standards in the Detection of Anal Canc...
https://doi.org/10.1097/LGT.0000000000000256
Journal of Lower Genital Tract Disease; Hillman RJ, Cuming T et. al.

Aug 26th, 2016 - To define minimum standards for provision of services and clinical practice in the investigation of anal cancer precursors. After initial face to face meetings of experts at the International Papillomavirus meeting in Lisbon, September 17 to 21, 2...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  124 results

Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
https://clinicaltrials.gov/ct2/show/NCT03946358

Jun 23rd, 2022 - 70% all cases of cervical cancer, 95% of anal cancers and about 70% of oropharyngeal cancers are linked to Human Papillomavirus (HPV) infection. HPV oncogenic proteins are trans-activators of telomerase. Indeed, E6 oncoprotein transactivates the h...

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT04444921

Jun 21st, 2022 - PRIMARY OBJECTIVE: I. To demonstrate that anti-PD-1 therapy in combination with carboplatin/weekly paclitaxel results in improved progression-free survival (PFS) versus systemic chemotherapy alone. SECONDARY OBJECTIVES: I. To demonstrate that anti...

Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
https://clinicaltrials.gov/ct2/show/NCT02135419

Jun 21st, 2022 - PRIMARY OBJECTIVES: The primary objective of this study has been completed for efficacy. I. To determine the effectiveness of treating anal HSIL to reduce the incidence of anal cancer in human immunodeficiency virus (HIV)-infected men and women. S...

LET-IMPT and Standard Chemotherapy in Treating Patients With Newly Diagnosed Stage I-III Anal Canal Squamous Cell Cancer
https://clinicaltrials.gov/ct2/show/NCT03690921

Jun 21st, 2022 - PRIMARY OBJECTIVES: I. To assess physician-reported acute grade 3 or greater gastrointestinal, genitourinary and hematologic toxicities at 12 weeks post-treatment for patients treated with linear energy transfer (LET)-optimized, intensity-modulate...

Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
https://clinicaltrials.gov/ct2/show/NCT02199236

Jun 16th, 2022 - The purpose of this study is to see what amount of radiation is safe to give to rectal or anal cancer patients who are being treated with a procedure called brachytherapy.

see more →

News  166 results

New Treatment Reduces Risk of Anal Cancer in People With HIV
https://www.medscape.com/viewarticle/975710

Jun 16th, 2022 - It all began with the question, "Has your butt been getting enough attention?" Though that may seem unorthodox, it led researchers to discovering a treatment that may help prevent anal cancer in people with HIV/AIDS. It's still featured on their s...

The benefits of conducting clinical research in private practice
https://www.mdedge.com/gihepnews/article/254038/mixed-topics/benefits-conducting-clinical-research-private-practice
Paul Feuerstadt, MD, FACG, AGAF, Louis Korman, MD, FACG

Apr 25th, 2022 - Most people believe that, if you want to conduct clinical research, the best path is going into academic medicine. However, for physicians who want both the benefits of practicing in the community setting and a career in research, there are many w.

FDA OKs First Condom for Anal Sex
https://www.medscape.com/viewarticle/969174

Feb 25th, 2022 - The first condom specifically designed for use during anal sex has gained FDA approval. Anal intercourse is considered to be much riskier than vaginal sex for the transmission of infections such as HIV and HPV, a risk factor for anal cancer, agenc...

Immunotherapy Outcomes in HPV-Associated Head and Neck Cancer Fuel Investigative Efforts
https://www.onclive.com/view/immunotherapy-outcomes-in-hpv-associated-head-and-neck-cancer-fuel-investigative-efforts

Feb 23rd, 2022 - Promising data from studies evaluating immunotherapy and cellular therapy for patients with head and neck cancers associated with human papilloma virus (HPV) have helped to widen the treatment landscape. However, many clinical questions remain una...

Full Results of Anal Cancer Study Point to Barriers to Care
https://www.medscape.com/viewarticle/968817

Feb 18th, 2022 - Reports based on a press release in October suggested it, but now the full data tell the story: Early monitoring and treatment of anal high-grade squamous intraepithelial lesions (HSIL) cut risk for anal cancer by 57% in people living with HIV. "W...

see more →

Patient Education  7 results see all →